VERA EBITDA
Vera Therapeutics Inc Class A · EBITDA
VERA EBITDA
Latest reported-$393.82Mperiod ending
VERA TTM EBITDA (-$50.41M → -$393.82M)
TTM EBITDA
High-resolution chart · PNG
VERA ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| -393,823,000 | |
| -360,868,000 | |
| -291,616,000 | |
| -244,057,000 | |
| -210,525,000 | |
| -167,768,000 | |
| -144,417,000 | |
| -130,080,000 | |
| -104,563,000 | |
| -91,513,000 | |
| -94,748,000 | |
| -99,382,000 | |
| -104,759,000 | |
| -100,753,000 | |
| -88,010,000 | |
| -73,009,000 | |
| -56,029,000 | |
| -44,691,000 | |
| -32,412,000 | |
| -56,535,250 | |
| -52,706,250 | |
| -52,748,250 | |
| -50,411,250 |